SELECTIVE
ANTI-MARCKS
TECHNOLOGIES
Biomarck is developing technology that utilizes targeted anti-MARCKS technology for the treatment of Cancer, Acute Respiratory Distress Syndrome (ARDS), and hard to treat diseases
Proud to be recognized for 2019 “30 Best Companies of the year” CIO Bulletin and 2018 Winner” and Best Pipeline of Promise”, BIO 2018